GLP-2 receptor drugs for Short Bowel Syndrome

2 tracked GLP-2 receptor drugs in the Short Bowel Syndrome race. The class explanation lives on the GLP-2 receptor page; the full indication pipeline across every mechanism is on the Short Bowel Syndrome page.

1 approved / phase 41 Phase 3

Head-to-head evidence: apraglutide vs teduglutide (Gattex)

The roster

← all GLP-2 receptor drugs